Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of MI078 Capsule in Patients With Postpartum Depression

NCT06963580 is registered in ClinicalTrials.gov with Nanjing Minova Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT06963580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of MI078 Capsule in Patients With Postpartum Depression
Lead sponsor
Nanjing Minova Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
September 9, 2024
Completion date
August 7, 2025
Enrollment
72 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression